India-based Syngene acquires its first US biologics site
The contract biotech company plans to invest around $50 million to buy and renovate a Baltimore facility as it shifts more ...
MIT Technology Review17h
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Barchart on MSN15h
Gilead Sciences - Leader in HIV Medicines
Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...
A Pill to Prevent COVID-19 Shows Promise
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Medscape10h
Ensitrelvir Shows Promise for COVID-19 Prevention Following Exposure
The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...
STAT14h
Altimmune to study obesity drug in alcohol use disorder, following Eli Lilly
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
CeSPIACE: A broad spectrum peptide inhibitor against variable SARS-CoV-2 spikes
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
PharmiWeb18h
Polyclonal Antibody Market Poised for Growth, Expected to Hit USD2.0 Billion by 2034 at 5.5% CAGR- TMR
The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...
Bromobenzene Market Expands as Demand Surges in Pharmaceuticals and Agrochemicals, Estimated at USD 1,853.90 Million by 2032 | Report by SNS Insider
The Bromobenzene market is driven by increasing applications in pharmaceuticals and chemical manufacturing, alongside rising demand for specialty chemicals.Austin, March 14, 2025 (GLOBE NEWSWIRE) -- ...